Dr. Alessandro A. Giambartolomei, MD

Dr. Giambartolomei practices at St Josephs Medical - Liverpool (4820 W Taft Rd) in Liverpool, New York.

Dr. Giambartolomei's NPI, 1730175241, was assigned on September 21, 2005. Dr. Giambartolomei holds Guam license M1918.

Dr. Giambartolomei's primary practice is St Josephs Medical - Liverpool (4820 W Taft Rd), at 4820 W Taft Rd, Liverpool, NY 13088. The practice phone is (315) 452-2828.

Dr. Giambartolomei's primary practice is St Josephs Medical - Liverpool (4820 W Taft Rd) in Liverpool, New York. Dr. Giambartolomei is also affiliated with St. Joseph's Health Hospital. The medical group on file is St. Joseph's Physicians Primary Care Center - OB/GYN. Dmand AI also links Dr. Giambartolomei to 1 more hospital, 4 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Giambartolomei practices, 4 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Giambartolomei's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dmand AI has Dr. Giambartolomei's licenses on file in 2 states: Guam and New York.

CMS data shows 692 Medicare services from Dr. Giambartolomei across 6 procedure codes in 2024, for 288 Medicare patients. Medicare paid $13,561 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 288 Medicare patients who saw Dr. Giambartolomei in 2024. The largest group is 65 to 74, with 96 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 22% are also on Medicaid. Their average risk score is 3.15, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Giambartolomei's median patient age at 67, with 44% women.

In 2024, Dr. Giambartolomei wrote 54 Medicare Part D claims. 100% of them were for generic drugs. CMS names the drug for 13 of them, across 1 drug with 11 or more claims each, at $142 in total drug cost. In 2023, CMS named 49 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Giambartolomei for performance year 2024, reported as part of a group. Dr. Giambartolomei accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 1 general payment to Dr. Giambartolomei from 1 drug or device company in 2018. Food and beverage make up the largest share, 100% of the total. Philips Electronics North America Corporation paid the most, $12.